Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy (Q34173018)

31 July 2017

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy (English)

1 reference

31 July 2017

Kristen Upson

9

0 references

Meira Epplein

object named as

Meira Epplein

7

0 references

Noel S. Weiss

11

object named as

Noel S Weiss

1 reference

31 July 2017

5

Lynda F Voigt

1 reference

31 July 2017

1

Susan D Reed

1 reference

31 July 2017

2

Katherine M Newton

1 reference

31 July 2017

Rochelle L Garcia

3

1 reference

31 July 2017

Kimberly H Allison

4

1 reference

31 July 2017

C Diana Jordan

6

1 reference

31 July 2017

Elizabeth Swisher

8

1 reference

31 July 2017

Kelly J Ehrlich

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Obstetrics and Gynecology

31 July 2017

1 reference

31 July 2017

116

1 reference

31 July 2017

365-373

1 reference

31 July 2017

2 Pt 1

1 reference

Incidence of endometrial hyperplasia

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Diagnosing endometrial hyperplasia: why is it so difficult to agree?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

The management of endometrial hyperplasia: an evaluation of current practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Problems in the differential diagnosis of endometrial hyperplasia and carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Endometrial lesions in uteri resected for atypical endometrial hyperplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Atypical Endometrial Hyperplasia: Grounds for Possible Misdiagnosis of Endometrial Adenocarcinoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949551

Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years

28 October 2018

1 reference

12 December 2020

Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment

1 reference

12 December 2020

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

12 December 2020

Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study

1 reference

12 December 2020

Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia

1 reference

12 December 2020

Endometrial hyperplasia and the risk of carcinoma

1 reference

12 December 2020

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma

1 reference

12 December 2020

A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

ACOG Practice Bulletin #65: Management of Endometrial Cancer

1 reference

12 December 2020

10.1097/AOG.0B013E3181E93330

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference